22nd Century Group (Nasdaq: XXII) has acquired GVB Biopharma. Read the press release here
| Date | Form | Description | XBRL | Pages | |
|---|---|---|---|---|---|
| 03/22/21 | 4 | Statement of changes in beneficial ownership of securities |
|
2 | |
| 03/22/21 | 4 | Statement of changes in beneficial ownership of securities |
|
2 | |
| 03/22/21 | 4 | Statement of changes in beneficial ownership of securities |
|
2 | |
| 03/22/21 | 4 | Statement of changes in beneficial ownership of securities |
|
2 | |
| 03/19/21 | 4 | Statement of changes in beneficial ownership of securities |
|
2 | |
| 03/17/21 | 4 | Statement of changes in beneficial ownership of securities |
|
2 | |
| 03/16/21 | 4 | Statement of changes in beneficial ownership of securities |
|
2 | |
| 03/11/21 | 10-K | Annual report pursuant to Section 13 and 15(d) |
|
   |
87 |
| 03/11/21 | 8-K | Current report filing |
|
|
28 |
| 02/26/21 | 4 | Statement of changes in beneficial ownership of securities |
|
2 |
